Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Positron Emission Tomography
100%
Receptor Binding
69%
Radiopharmaceuticals
66%
D2 Receptor
53%
Striatal
36%
No-carrier-added
35%
N-methylation
33%
Radiochemical Yield
27%
Radioligand
27%
Methyl
26%
Aromatics
25%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
22%
Manganese
21%
Parkinsonism
21%
Specific Binding
20%
Manganese Exposure
20%
D2-like
19%
Spiperone
19%
Radiation Dosimetry
19%
Radiosynthesis
18%
123I
18%
Fluoro
18%
Dopamine
17%
Regiospecific
17%
Dopamine D2 Receptor (DRD2)
17%
Radiotracer
16%
Exposed Workers
16%
Striatal Dopamine
16%
Liver
15%
Automated Production
15%
Putamen
15%
Bromine
14%
Specific Activity
14%
Dopaminergic Pathway
13%
Parkinson's Disease
13%
Vesicular Acetylcholine Transporter (VAChT)
13%
Substantia Nigra
12%
Dihydrotetrabenazine
12%
Dystonia
12%
Striatum
12%
Radioiodination
12%
Caudate
12%
Low-density Lipoprotein
11%
L-DOPA
11%
5-HT2A Receptor
11%
Gallium
11%
Fluorodeoxyglucose
11%
Obesity
11%
Human Subjects
10%
PET Study
10%
Neuroscience
Positron Emission Tomography
87%
Fluorine-18
80%
Receptor Binding
59%
In Vivo
47%
Receptor
39%
Positron Emission Tomography
39%
Dopaminergic
33%
Radioligand
25%
Parkinsonism
24%
Tetrahydropyridine
22%
Dystonia
21%
Parkinson's Disease
19%
Putamen
18%
Radiopharmaceutical
18%
Dopamine Receptor
16%
D2-Like Receptor
14%
Dopamine Receptor D2
13%
Behavior (Neuroscience)
12%
Spiperone
12%
5-HT2A Receptor
11%
Cholinergic
11%
L-DOPA
11%
Body Mass Index
10%
In Vitro
9%
Substantia nigra
8%
Altanserin
8%
Striatum
8%
Cerebellum
8%
Iodine-123
7%
Fluorodopa
7%
Stereotypic Movement Disorder
7%
Basal Ganglia
6%
Vesicular Acetylcholine Transporter
5%
Single-Photon Emission Computed Tomography
5%
Midbrain
5%
Antipsychotic
5%
Magnetic Resonance Imaging
5%
Nucleus Accumbens
5%
Ventral Tegmental Area
5%
Neurotoxin
5%
Serotonergic
5%